You are here:  > Home Page > Publications

2015 Subscriptions available

Order the next volume of Antiviral Therapy today.

ARV access in resource-poor countries

Highly anticipated special issue with UNAIDS now available

Follow us on Twitter

International Medical Press is now on Twitter. Join our conversation today.
Antiviral Chemistry & Chemotherapy and Antiviral Therapy


International Medical Press publishes two peer-reviewed journals:

Antiviral Therapy is one of the leading journals in virology (2013 ISI impact factor: 3.14). The journal is devoted to publishing high quality articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases.

Antiviral Chemistry & Chemotherapy is an online peer-reviewed journal publishing the results of original research concerned with the biochemistry, mode of action, chemistry, pharmacology and virology of antiviral compounds.


Journal features

♦ Online submission and manuscript tracking via ScholarOne Manuscripts™
♦ Leading Editorial Boards ensuring high-quality standards
♦ Immediate online publication of all non-commissioned articles
♦ Inclusion in major indexing and abstracting services
♦ Worldwide readership 

Recently published in Antiviral Therapy

Rimsky et al. report long-term resistance to rilpivirine in the ECHO/THRIVE Phase III trials. At 96 weeks, resistance patterns were consistent with 48-week data, and suggest most virological failures and resistance-associated mutations occur during the first year of treatment. Overall, the evidence demonstrates rilpivirine is non-inferior to existing therapies for HIV-infected, treatment-naive patients. Read more here.

The Editorial Office welcomes queries about publishing supplements within the journal. Please visit the Supplements page for more information.

Copyright © Nucleus Global 2015. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.